Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04713371
Title A Phase 2 Trial for Patients With Metastatic Solid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rampart Health, L.L.C.

Advanced Solid Tumor


Cyclophosphamide + Ipilimumab + Pembrolizumab + Sargramostim

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.